{
    "organizations": [],
    "uuid": "8f8819f233741496a5e336a533cd22edabebcfd4",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sage-therapeutics-announces-propos/brief-sage-therapeutics-announces-proposed-public-offering-of-common-stock-idUSASB0C4JV",
    "ord_in_thread": 0,
    "title": "BRIEF-Sage Therapeutics Announces Proposed Public Offering Of Common Stock",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 7 (Reuters) - Sage Therapeutics Inc:\n* SAGE THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK\n* SAGE THERAPEUTICS INC - HAS COMMENCED AN UNDERWRITTEN PUBLIC OFFERING OF $575.0 MILLION OF ITS COMMON STOCK\n* SAGE THERAPEUTICS - ALSO INTENDS TO GRANT UNDERWRITERS 30-DAY OPTION TO BUY UP TO AN ADDITIONAL $86.3 MILLION OF COMMON STOCK OFFERED IN PUBLIC OFFERING Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-08T05:08:00.000+02:00",
    "crawled": "2018-02-09T05:50:32.062+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "sage",
        "therapeutic",
        "inc",
        "sage",
        "therapeutic",
        "announces",
        "proposed",
        "public",
        "offering",
        "common",
        "stock",
        "sage",
        "therapeutic",
        "inc",
        "commenced",
        "underwritten",
        "public",
        "offering",
        "million",
        "common",
        "stock",
        "sage",
        "therapeutic",
        "also",
        "intends",
        "grant",
        "underwriter",
        "option",
        "buy",
        "additional",
        "million",
        "common",
        "stock",
        "offered",
        "public",
        "offering",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}